359 related articles for article (PubMed ID: 16206835)
1. Iridoids as DNA topoisomerase I poisons.
Gálvez M; Martín-Cordero C; Ayuso MJ
J Enzyme Inhib Med Chem; 2005 Aug; 20(4):389-92. PubMed ID: 16206835
[TBL] [Abstract][Full Text] [Related]
2. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
[TBL] [Abstract][Full Text] [Related]
3. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
4. Effects of Olive Metabolites on DNA Cleavage Mediated by Human Type II Topoisomerases.
Vann KR; Sedgeman CA; Gopas J; Golan-Goldhirsh A; Osheroff N
Biochemistry; 2015 Jul; 54(29):4531-41. PubMed ID: 26132160
[TBL] [Abstract][Full Text] [Related]
5. F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.
Perrin D; van Hille B; Barret JM; Kruczynski A; Etiévant C; Imbert T; Hill BT
Biochem Pharmacol; 2000 Apr; 59(7):807-19. PubMed ID: 10718339
[TBL] [Abstract][Full Text] [Related]
6. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
7. Gossypol interferes with both type I and type II topoisomerase activities without generating strand breaks.
Senarisoy M; Canturk P; Zencir S; Baran Y; Topcu Z
Cell Biochem Biophys; 2013 May; 66(1):199-204. PubMed ID: 23161103
[TBL] [Abstract][Full Text] [Related]
8. DNA sequence selectivity of topoisomerases and topoisomerase poisons.
Capranico G; Binaschi M
Biochim Biophys Acta; 1998 Oct; 1400(1-3):185-94. PubMed ID: 9748568
[TBL] [Abstract][Full Text] [Related]
9. Anthocyanin-rich blackberry extract suppresses the DNA-damaging properties of topoisomerase I and II poisons in colon carcinoma cells.
Esselen M; Boettler U; Teller N; Bachler S; Hutter M; Rufer CE; Skrbek S; Marko D
J Agric Food Chem; 2011 Jul; 59(13):6966-73. PubMed ID: 21599019
[TBL] [Abstract][Full Text] [Related]
10. Genotoxic effects of topoisomerase poisoning and PARP inhibition on zebrafish embryos.
Karapetian M; Tsikarishvili S; Kulikova N; Kurdadze A; Zaalishvili G
DNA Repair (Amst); 2020 Mar; 87():102772. PubMed ID: 31877465
[TBL] [Abstract][Full Text] [Related]
11. Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerases.
Jobson AG; Willmore E; Tilby MJ; Mistry P; Charlton P; Austin CA
Cancer Chemother Pharmacol; 2009 Apr; 63(5):889-901. PubMed ID: 18679685
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
Wilstermann AM; Osheroff N
Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activities of topopyrones.
Zaleski PA; Maini R; Leiris SJ; Elban MA; Hecht SM
J Nat Prod; 2012 Apr; 75(4):577-85. PubMed ID: 22462811
[TBL] [Abstract][Full Text] [Related]
14. Coordinating the two protomer active sites of human topoisomerase IIalpha: nicks as topoisomerase II poisons.
Deweese JE; Osheroff N
Biochemistry; 2009 Feb; 48(7):1439-41. PubMed ID: 19166355
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
Schaack J; Schedl P; Shenk T
J Virol; 1990 Jan; 64(1):78-85. PubMed ID: 2152835
[TBL] [Abstract][Full Text] [Related]
16. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
17. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Ling YH; Andersson BS; Nelson JA
Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jung MJ; Nam JM; Na Y; Cho WJ; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Mar; 18(6):2245-2254. PubMed ID: 20188578
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of DNA topoisomerases II and/or I by pyrazolo[1,5-a]indole derivatives and their growth inhibitory activities.
Umemura K; Mizushima T; Katayama H; Kiryu Y; Yamori T; Andoh T
Mol Pharmacol; 2002 Oct; 62(4):873-80. PubMed ID: 12237334
[TBL] [Abstract][Full Text] [Related]
20. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
Thielmann HW; Popanda O; Gersbach H; Gilberg F
Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
